Maximum quantity allowed is 999
请选择数量
CAS RN: 101152-94-7 | 產品號碼: M2133
Milnacipran Hydrochloride
![Milnacipran Hydrochloride No-Image](/medias/M2133.jpg?context=bWFzdGVyfHJvb3R8NjA2MjF8aW1hZ2UvanBlZ3xhRGxpTDJnM05TODRPVEl5TlRBNE1qTXdOamcyTDAweU1UTXpMbXB3Wnd8NmFmMDBjYzJjODE2MTYyYTAwMDU4ZGMwZGIxOTEzNjk1ODkxMmU0YWI4ZjM4NGZkYTI2YzMyMmNkMTY0NDBhNg)
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | M2133 |
純度/分析方法 | >98.0%(T)(HPLC) |
分子式 / 分子量 | C__1__5H__2__2N__2O·HCl = 282.81 |
外觀與形狀(20°C) | Solid |
儲存條件 | Refrigerated (0-10°C) |
應避免的情況 | Heat Sensitive |
包裝和容器 | 500MG-Glass Bottle with Plastic Insert (閲覽圖片), 50MG-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 101152-94-7 |
相關CAS RN | 92623-85-3 |
Reaxys-RN | 6078861 |
PubChem Substance ID | 125307702 |
Merck Index(14) | 6194 |
MDL編號 | MFCD00901293 |
產品規格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
NMR | confirm to structure |
性質
熔點 | 181 °C(dec.) |
水溶性 | Soluble |
GHS
圖形表示 |
![]() |
信號詞 | Danger |
危險性說明 | H301 : Toxic if swallowed. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相關法規
RTECS # | GZ1014010 |
運輸資料
UN編號 | UN2811 |
類別 | 6.1 |
包裝類別 | III |
HS編碼* | 2924.29-000 |
Application
Milnacipran hydrochloride: A Selective Serotonin Noradrenaline Reuptake Inhibitor (SNRI)
Milnacipran hydrochloride is a selective serotonin noradrenaline reuptake inhibitor (SNRI) which acts by inhibiting noradrenaline (norepinephrine) and serotonin (5-hydroxytrytamine; 5-HT) reuptake at presynaptic sites. Milnacipran has unique characteristics that distinguish it from the other SNRIs, venlafaxine [V0110] and duloxetine [D4223], such as inhibition of noradrenaline reuptake with approximately 3-fold higher potency in vitro than serotonin. Milnacipran has no significantt affinity for other neurotransmitter receptors, such as serotonergic, α- and β-adrenergic, muscarinic, histamine, dopamine, opioid, benzodiazepine, and γ-aminobutyric acid (GABA) receptors in vitro. Milnacipran does not inhibit the activity of human monoamine oxidases (MAO-A and MAO-B) or acetylcholinesterase. (The product is for research purpose only.)
References
- Selective serotonin/noradrenaline reuptake inhibitors (SNRIs). Pharmacology and therapeutic potential in the treatment of depressive disorders (a review)
- Neurochemical and behavioral characterization of Milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats
- Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity
- High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum
- A stability indicating U-HPLC method for milnacipran in bulk drugs and pharmaceutical dosage forms
考研文獻
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。